Starlight Cardiovascular Awarded $2M NIH SBIR Phase II Grant to Develop Pediatric Cardiology Device

/PRNewswire/ -- Starlight Cardiovascular, Inc., a company developing pediatric cardiovascular medical devices, announced that it has been awarded a Small...

Related Keywords

Mark Galantowicz ,Blood Institute ,National Institutes Of Health ,Small Business Innovation Research ,Heart Center At Nationwide Children Hospital ,Prnewswire Starlight Cardiovascular Inc ,National Heart ,Pulmonary Flow Restrictor ,Congenital Heart ,National Institutes ,Pulmonary Flow ,Congenital Heart Disease ,Pulmonary Artery Flow Restrictors ,Cardiothoracic Surgery ,Heart Center ,Nationwide Children ,Hypoplastic Left Heart Syndrome ,Pulmonary Flow Restrictors ,Starlight Cardiovascular ,